Cargando…

Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch

BACKGROUND: To illustrate challenges of imaging interpretation in patients with oligodendroglioma seen at a referral center and evaluate interrater reliability. METHODS: Two neuro-oncologists reviewed diagnostic preradiation MRIs of oligodendroglioma patients; interrater reliability was calculated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aboud, Orwa, Shah, Ritu, Vera, Elizabeth, Burton, Eric, Theeler, Brett, Wu, Jing, Boris, Lisa, Quezado, Martha, Reyes, Jennifer, Wall, Kathleen, R Gilbert, Mark, S Armstrong, Terri, Penas-Prado, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988255/ https://www.ncbi.nlm.nih.gov/pubmed/35142534 http://dx.doi.org/10.2217/cns-2021-0005

Ejemplares similares

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
por: Yu, Guangyang, et al.
Publicado: (2021)

INNV-27. AN INNOVATIVE VIRTUAL MULTI-INSTITUTIONAL, MULTIDISCIPLINARY NEURO-ONCOLOGY TUMOR BOARD: THE NIH-NOB EXPERIENCE DURING THE COVID-19 PANDEMIC
por: Rogers, James, et al.
Publicado: (2021)

The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
por: Jammula, Varna, et al.
Publicado: (2022)

Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
por: Merchant, Mythili, et al.
Publicado: (2022)

Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey
por: Rogers, James L, et al.
Publicado: (2020)

The prevalence of altered body image in patients with primary brain tumors: an understudied population
por: Rowe, Lindsay, et al.
Publicado: (2020)

Oligodendroglioma in childhood.
por: Wang, K. C., et al.
Publicado: (1993)

Imaging of oligodendroglioma
por: Smits, Marion
Publicado: (2016)

Pediatric brainstem oligodendroglioma
por: Mohindra, Sandeep, et al.
Publicado: (2012)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review
por: Frederico, Stephen C., et al.
Publicado: (2023)

Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
por: Rincon-Torroella, Jordina, et al.
Publicado: (2022)

Imaging in neuro-oncology
por: Nandu, Hari, et al.
Publicado: (2018)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Multicystic oligodendroglioma with calvarial destruction
por: Bajaj, Ajay
Publicado: (2014)

Oligodendroglioma presenting as chronic mania
por: SAHA, Rahul, et al.
Publicado: (2015)

Osteosclerosis Secondary to Metastatic Oligodendroglioma
por: Maloney, Patrick R., et al.
Publicado: (2017)

QOLP-19. FINANCIAL TOXICITY AND DISTRESS DURING THE COVID-19 PANDEMIC IN PEOPLE LIVING WITH PRIMARY BRAIN TUMORS
por: Leeper, Heather, et al.
Publicado: (2021)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

Developing a virtual neuro-oncology journal club series during the COVID-19 pandemic to promote interprofessional education and collaborative research
por: Rogers, James L, et al.
Publicado: (2022)

Editorial: Methods in neuro-oncology and neurosurgical oncology
por: Zoli, Matteo, et al.
Publicado: (2023)

NCOG-23. PATIENT-REPORTED SYMPTOM BURDEN AND INTERFERENCE: A COMPARISON BETWEEN COVID-19 PANDEMIC YEAR AND NORMATIVE DATA IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Pillai, Valentina, et al.
Publicado: (2021)

QOLP-37. MOOD DISTURBANCE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS DURING THE COVID-19 PANDEMIC
por: Polskin, Lily, et al.
Publicado: (2021)

Genomic and molecular neuro-oncology
Publicado: (2004)

The Danish Neuro-Oncology Registry
por: Hansen, Steinbjørn
Publicado: (2016)

Therapeutic Options in Neuro-Oncology
por: Afonso, Mariana, et al.
Publicado: (2022)

CONCENTRIC LAMINATION OF GLIAL PROCESSES IN OLIGODENDROGLIOMAS
por: Robertson, David M., et al.
Publicado: (1962)

Oligodendroglioma Arising in Mature Cystic Teratoma
por: Ünal, Betül, et al.
Publicado: (2014)

Multiple Sclerosis and Oligodendroglioma: An Exceptional Association
por: Carvalho, Ana Teresa, et al.
Publicado: (2014)

Oligodendroglioma: pathology, molecular mechanisms and markers
por: Wesseling, Pieter, et al.
Publicado: (2015)

Clinical management of grade III oligodendroglioma
por: Simonetti, G, et al.
Publicado: (2015)

TCF12 is mutated in anaplastic oligodendroglioma
por: Labreche, Karim, et al.
Publicado: (2015)

Multiple Extraneural Metastases of Anaplastic Oligodendroglioma
por: Aydemir, Fatih, et al.
Publicado: (2018)

Genetic and epigenetic stability of oligodendrogliomas at recurrence
por: Aihara, Koki, et al.
Publicado: (2017)

Paraneoplastic dermatomyositis in a patient with an oligodendroglioma
por: Kim, Esther, et al.
Publicado: (2019)

Oligodendroglioma: A Review of Management and Pathways
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Multifocal oligodendroglioma with callosal and brainstem involvement
por: Mubarak, Fatima, et al.
Publicado: (2022)

A rare, giant, anaplastic oligodendroglioma
por: Tuan, Pham Anh, et al.
Publicado: (2023)

Conventional and emerging treatments of astrocytomas and oligodendrogliomas
por: Kessler, Tobias, et al.
Publicado: (2022)

Genomic alterations of oligodendrogliomas at distant recurrence
por: Liu, Guanzheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4126tjehm63dm2onl6q0bldrhr